Rai et al., PubMed Abstract (Curr Med Chem 8(2):101-19) Feb. 2001.* |
Keck, PubMed Abstract (Pancreatology 1(6):656-61), 2001.* |
Barton et al., Eight Membered Rings—Mixed Heteroatom Systems, Comprehensive Organic Chemistry, vol. 4, pp. 1166-1170, 1979.* |
Augstein, J., et al., “Aryloxyalkylaminoguanidines. Their Synthesis and Biological Properties,” J. Med. Chem. 10:391-400, American Chemical Society (1967). |
Barrett, A.J., “Proteinase inhibitors: potential drugs?” in: Enzyme Inhibitors as Drugs, Sandler, M., ed., The MacMillan Press Ltd., London, England, pp. 219-229 (1979). |
Baugh, R.J. and Travis, J., “Human Leukocyte Granule Elastase: Rapid Isolation and Characterization,” Biochemistry 15:836-841, American Chemical Society (1976). |
Bodor, N., “Novel Approaches in Prodrug Design,” Drugs of the Future VI:165-182, J.R. Prous S.A. Publishers (1981). |
Brown, F.J., et al., “Design of Orally Active, Non-Peptidic Inhibitors of Human Leukocyte Elastase,” J. Med. Chem. 37:1259-1261, American Chemical Society (1994). |
Bundgaard, H., “Design of prodrugs: Bioreversible derivatives for various functional groups and chemical entities,” in: Design of Prodrugs, Bundgaard, H., Ed., Elsevier Science Publishers B. V., Amsterdam, The Netherlands, pp. 1-92 (1985). |
Claeson, G., “Synthetic peptides and peptidomimetics as substrates and inhibitors of thrombin and other proteases in the blood coagulation system,” Blood Coagulation and Fibrinolysis 5:411-436, Rapid Communications (1994). |
Coughlin, S.R., “Molecular Mechanisms of Thrombin Signaling,” Semin. Hematology 31:270-277, W.B. Saunders Co. (1994). |
Cuypers, H.T., et al., “Sulfhydryl Content of Bovine Eye Lens Leucine Aminopeptidase,” J. Biol. Chem. 257:7086-7091, American Society of Biological Chemists, Inc. (1982). |
Edwards, P.D., et al., “Design, Synthesis, and Kinetic Evaluation of a Unique Class of Elastase Inhibitors, the Peptidyl α-Ketobenzoxazoles, and the X-ray Crystal Structure of the Covalent Complex between Porcine Pancreatic Elastase and Ac-Ala-Pro-Val-2-Benzoxazole,” J. Am. Chem. Soc. 114:1854-1863, American Chemical Society (1992). |
Harker, L.A., “Strategies for inhibiting the effects of thrombin,” Blood Coagulation and Fibrinolysis 5(Suppl. 1):s47-s58, Rapid Communications (1994). |
Jeong, J.-H., et al., “Cyclic Guanidino-Sugars with Low pKa as Transition-State Analog Inhibitors of Glycosidases: Neutral Instead of Charged Species Are The Active Forms,” J. Amer. Chem. Soc. 118:4227-4234, American Chemical Society (1996). |
Khadilkar, B.M. and Samant, S.D., “Synthesis and pharmacology of 2-[3-(4-aryl-1-piperazinyl)-2-hydroxypropyl/3-oxopropyl/propoxy]-1H-isoindole-1,3(2H)-diones,” Ind. J. Chem. 32B:1137-1142, Publications & Information Directorate, CSIR (1993). |
Kim, K.S., et al., “Preparation of Argatroban Analog Thrombin Inhibitors with Reduced Basic Guanidine Moiety, And Studies of Their Cell Permeability and Antithrombotic Activities,” Med. Chem. Res. 6:377-383, Birkhäuser Boston, Inc. (1996). |
Kimball, S.D., “Challenges in the development of orally bioavailable thrombin active site inhibitors,” Blood Coagulation and Fibrinolysis 6:511-519, Rapid Science Publishers (1995). |
Lee, S.-L., et al., “Amidino and Guanidino substituted boronic acid inhibitors of trypsin-like enzymes,” CAPLUS Accession No. 1997:594514, Abstract of U.S. patent 5,658,885 (1997). |
Lefkovits, J. and Topol, E.J., “Direct Thrombin Inhibitors in Cardiovascular Medicine,” Circulation 90:1522-1536, American Heart Association, Inc. (1994). |
Mack, H., et al., “Design, Synthesis, and Biological Activity of Novel Rigid Amidino-Phenylalanine Derivatives as Inhibitors of Thrombin,” J. Enzyme Inhib. 9:73-86, Harwood Academic Publishers GmbH (1995). |
Notari, R.E., “Theory and Practice of Prodrug Kinetics,” Meth. Enzym. 112:309-323, Academic Press, Inc. (1985). |
Ozawa, H., et al., “Pharmacological Studies Aminoguanidines. I. Hypotensive and Some General Pharmacological Actions of Benzyl- and Benzylidene-hydrazino-3,4,5,6-tetrahydropyrimidines,” Yakugaku Zasshi 95:966-974, Pharmaceutical Society of Japan (1975). |
Ripka, W.C. and Vlasuk, G.P., “Chapter 8. Antithrombotics/Serine Proteases,” In: Annual Reports in Medicinal Chemistry-32, Bristol, J.A., Ed., Academic Press, Inc., New York, NY, pp. 71-89 (1997). |
Saulnier, M.G. et al., “An Efficient Method for the Synthesis of Guanidino Prodrugs,” Bioorg. & Med. Chem. Lett. 4:1985-1990, Pergamon Press (1994). |
Tapparelli, C., et al., “Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile,” Trends Pharmacol. Sci. 14:366-376, Elsevier Science Publishers Ltd. (1993). |
English language abstract of WO 96/32143 (Document AO2), Derwent World Patents Index, WPI Accession No. 96-476853/199647, 1996. |
Dialog File 351, Accession No. 518509, Derwent WPI English language abstract of DE 1 518 222 (Document AL1), 1969. |